GlassScriptPhysician profile
Therese Ann Tlapek
NPI 1851445035
$554.54
in general payments reported to CMS, 2019-2025
11 companies · $38.06 in 2025
The $38.06 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $44.99 · 2021: $29.76 · 2022: $257 · 2024: $19.29 · 2025: $38.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $115.52 | 2019 | |
| Organogenesis INC. | $114.68 | 2022 | |
| Stryker Corporation | $107.38 | 2022 | |
| Horizon Therapeutics Plc | $44.41 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $41.11 | 2022-2024 | Nuzyra |
| Sandoz INC. | $39.92 | 2019-2020 | |
| Acumed LLC | $29.76 | 2021 | |
| Convatec INC. | $21.06 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.00 | 2025 | Jublia |
| Orthofix Medical, INC. | $12.72 | 2022 | |
| Arthrosurface Incorporated | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Therese Tlapek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.